Senior insider sale
Chief Executive Officer at AXSOME THERAPEUTICS, INC. — senior position signals high conviction
$34.42M
149K shares
TABUTEAU HERRIOT plans to sell 149K shares of AXSOME THERAPEUTICS, INC. valued at approximately $34.42M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Acquired as compensation -- Stock Options
Compensation -- Cashless exercise / same-day sale
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/15/2017 | Acquired as compensation -- Stock Options Compensation -- Cashless exercise / same-day sale | 4.66K | — |
| Total | 4.66K | ||
Completed
Units to sell
20.17K
Market value
$4.26M
Units to sell
24.83K
Market value
$5.28M
Units to sell
24.83K
Market value
$5.93M
Units to sell
24.83K
Market value
$6.00M
Units to sell
24.84K
Market value
$5.95M
Units to sell
24.84K
Market value
$6.02M
Planned — Approximate Date
Units to sell
4.66K
Market value
$979.2K
Units
149K
Value
$34.42M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/5/2026 | 20.17K | $4.26M | — | Completed |
8/5/2026 | 24.83K | $5.28M | — | Completed |
7/1/2026 | 24.83K | $5.93M | — | Completed |
7/1/2026 | 24.83K | $6.00M | — | Completed |
6/9/2026 | 24.84K | $5.95M | — | Completed |
6/9/2026 | 24.84K | $6.02M | — | Completed |
| Planned — Approximate Date | ||||
8/6/2026 | 4.66K | $979.2K | NASD | Planned |
| Total | 149K | $34.42M | ||